TSLNC8 serves as a competitive endogenous RNA, attenuating the miR‐10b‐5p inhibitory effect on WWC3, thereby inhibiting the viability, migration and invasion of glioma cells and promoting glioma cell apoptosis. The gene discussed is WWC3; the disease is glioma.